FAS and prostate carcinoma: Another study indicated that CPT could significantly block activation of JNK and p38 MAPK, which suppressed the expression of Bcl-2 and eventually sensitized DU145 prostate cancer cells to Fas (APO1/CD95)-mediated apoptosis [26].